A Truncated CXCL10 Variant Influences Anti-Tumour Immunity in Ovarian Cancer Andrew N. Stephens Centre for Cancer Research MIMR-PHI Institute of Medical Research Clayton, VIC

First Page		Document Content
Date: 2014-10-21 20:20:23 Gynaecological cancer CXCR3 Dipeptidyl peptidase-4 CXCL10 Ovarian cancer Metastasis Chemokine Medicine Biology Cytokines		A Truncated CXCL10 Variant Influences Anti-Tumour Immunity in Ovarian Cancer Andrew N. Stephens Centre for Cancer Research MIMR-PHI Institute of Medical Research Clayton, VIC Add to Reading List Source URL: southernmelbcancersymposium.org Download Document from Source Website File Size: 1,68 MB Share Document on Facebook

	Annexure I INDIAN COUNCIL OF MEDICAL RESEARCH DIVISION OF EPIDEMIOLOGY & COMMUNICABLE DISEASES Achievements of the major research projects funded by ICMR for information/implementation Major leads : 1. DocID: 1a2Su - View Document
	Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal Jason S. Parka,b,c, Benjamin Rhaua,b, Aynur Hermanna,b, Krista A. McNallya,b, Carmen Zhoua,b, Delquin Gongb DocID: 18Gqj - View Document
	Distinguished Seminar September 8thNuska Tschammer- DocID: 16zTD - View Document
	A Truncated CXCL10 Variant Influences Anti-Tumour Immunity in Ovarian Cancer Andrew N. Stephens Centre for Cancer Research MIMR-PHI Institute of Medical Research Clayton, VIC DocID: 14Avm - View Document
	Faculty of Sciences Classroom Activity 10 Big Question: How do we unravel the causes of disease? Quiz DocID: 14pPd - View Document